NASDAQ OMX (NASDAQ: NDAQ) announces that the trading in Doxa AB (DOXA) shares commenced today on First North at NASDAQ OMX Stockholm. Doxa belongs to the Healthcare sector and is the sixth company to be admitted to trading on First North’s Nordic markets (Stockholm, Helsinki, Copenhagen and Iceland) in 2014.
Doxa is a Swedish-based company, developing, manufacturing and commercializing dental bioceramic products. Ceramir® Crown & Bridge, the first in a range of planned bioceramic dental products from Doxa, is an advanced dental cement used for the permanent fixture of dental crowns and bridges.
“Listing the company on First North is a milestone in our laid out plan,” said Torbjörn Larsson, CEO at Doxa. “It gives us a platform to continue to leverage the expansion of the Ceramir® technology, with new products, and into new markets. Thus building growth and profitability into Doxa, and adding long term value to our shareholders.”
“We are excited to welcome Doxa to First North and to our vibrant Healthcare sector,” said Adam Kostyal, Senior Vice President at NASDAQ OMX. “We continue to see a steady inflow of new, innovative companies at First North, and Doxa is a terrific example of how the public markets can support entreprenorial businesses with an ambition to grow.”
Doxa AB is using G&W Kapitalförvaltning AB as Certified Adviser.